Domain III of the envelope protein as a dengue vaccine targetMaría G. Guzmán, Gerardo Guillén, Lisset Hermida et al.|Expert Review of Vaccines|2010Cited by 125
OXIDATIVE STRESS IN ADULT DENGUE PATIENTSLizette Gil, María G. Guzmán, Gregorio Martı́nez et al.|American Journal of Tropical Medicine and Hygiene|2004Cited by 89
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in miceIris Valdés, Lisset Hermida, Lídice Bernardo et al.|Virology|2009Cited by 65
Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidisIris Valdés, Gerardo Guillén, Jorge Martı́n et al.|Vaccine|2008Cited by 47
A fragment of the envelope protein from dengue‐1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in miceLisset Hermida, María G. Guzmán, Rayner Rodrı́guez et al.|Biotechnology and Applied Biochemistry|2004Cited by 34